| Autor: |
Dhara, Debashis, Baliban, Scott M., Huo, Chang‐Xin, Rashidijahanabad, Zahra, Sears, Khandra T., Nick, Setare Tahmasebi, Misra, Anup Kumar, Tennant, Sharon M., Huang, Xuefei |
| Předmět: |
|
| Zdroj: |
Chemistry - A European Journal; 12/4/2020, Vol. 26 Issue 68, p15953-15968, 16p |
| Abstrakt: |
With the emergence of multidrug resistant Salmonella strains, the development of anti‐Salmonella vaccines is an important task. Currently there are no approved vaccines against Salmonella Paratyphi A, the leading cause of paratyphoid fever. To fill this gap, oligosaccharides corresponding to the O‐polysaccharide repeating units from the surface of Salmonella Paratyphi A have been synthesized through convergent stereoselective glycosylations. The synthetic glycan antigen was conjugated with a powerful immunogenic carrier system, the bacteriophage Qβ. The resulting construct was able to elicit strong and long‐lasting anti‐glycan IgG antibody responses, which were highly selective toward Salmonella Paratyphi A associated glycans. The availability of well‐defined glycan antigen enabled the determination that one repeating unit of the polysaccharide is sufficient to induce protective antibodies, and the paratose residue and/or the O‐acetyl modifications on the backbone are important for recognition by antibodies elicited by a Qβ‐tetrasaccharide conjugate. Immune sera provided excellent protection to mice from lethal challenge with Salmonella Paratyphi A, highlighting the potential of the synthetic glycan‐based vaccine. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
|
Nepřihlášeným uživatelům se plný text nezobrazuje |
K zobrazení výsledku je třeba se přihlásit.
|
